Colgate/$CL
1D1W1MYTD1Y5YMAX
Capital at risk
About Colgate
Since its founding in 1806, Colgate-Palmolive has grown into a leading player in the household and personal care industry. In addition to its namesake oral care line (which accounts for more than 40% of its total sales), the firm manufactures shampoos, shower gels, deodorants, and home care products sold in over 200 countries. International sales account for about 70% of its total business, including nearly half from emerging regions. It also owns the specialty pet food maker Hill's (which accounts for almost one-fourth of its sales), where the majority of its products are sold through veterinarians and specialty pet retailers.
- Ticker
- $CL
- Sector
- Consumer Essentials
- Primary listing
- NYSE
- Employees
- 33,600
- Headquarters
- New York, United States
- Website
- www.colgatepalmolive.com
Colgate Metrics
BasicAdvanced
$70B
34.51
$2.53
0.32
$2.10
2.42%
Price and volume
Market cap
$70B
Beta
0.32
52-week high
$99.33
52-week low
$74.55
Average daily volume
4.4M
Dividend rate
$2.10
Financial strength
Current ratio
1.032
Quick ratio
0.559
Long term debt to equity
13.882
Total debt to equity
13.882
Dividend payout ratio (TTM)
89.40%
Interest coverage (TTM)
17.09%
Profitability
EBITDA (TTM)
4,983
Gross margin (TTM)
60.43%
Net profit margin (TTM)
9.68%
Operating margin (TTM)
20.63%
Effective tax rate (TTM)
26.48%
Revenue per employee (TTM)
$630,000
Management effectiveness
Return on assets (TTM)
15.84%
Return on equity (TTM)
267.37%
Valuation
Price to earnings (TTM)
34.515
Price to revenue (TTM)
3.339
Price to book
295.46
Price to tangible book (TTM)
-16
Price to free cash flow (TTM)
18.217
Free cash flow yield (TTM)
5.49%
Free cash flow per share (TTM)
4.801
Dividend yield (TTM)
2.40%
Forward dividend yield
2.42%
Growth
Revenue change (TTM)
5.25%
Earnings per share change (TTM)
-28.82%
3-year revenue growth (CAGR)
4.06%
10-year revenue growth (CAGR)
3.10%
3-year earnings per share growth (CAGR)
12.14%
10-year earnings per share growth (CAGR)
5.02%
3-year dividend per share growth (CAGR)
3.41%
10-year dividend per share growth (CAGR)
3.17%
What the Analysts think about Colgate
Analyst ratings (Buy, Hold, Sell) for Colgate stock.
Analyst projections of the future price of Colgate stock.
Bulls say / Bears say
Second-quarter execution was resilient: sales rose 4.9%, organic sales grew 2.4%, base-business EPS increased 8% and gross margin expanded 140 basis points to 61.5%. Colgate also raised its 2026 base-business EPS outlook to mid-single-digit growth and now expects roughly flat gross margin. (Colgate-Palmolive)
Colgate retains strong positions in its core categories, with 41.3% global toothpaste share and 32.7% manual-toothbrush share year to date. Organic sales grew in four of five divisions, with emerging markets delivering solid mid-single-digit growth. (Colgate-Palmolive)
Hill’s offers a credible growth engine through premium, science-led pet nutrition: management reported roughly 4% growth excluding private label in the second quarter and share gains across key segments. The new Science Diet Single Protein fresh-food launch gives Hill’s another route to capture premium demand. (StockAnalysis, Pet Food Processing)
North America remains the weak spot: organic sales fell 3% in the second quarter and volume dropped 3.9%, as slower category growth, market-share losses, stronger competition and retailer stock reductions weighed on demand. (Reuters)
New 10% and 12.5% tariffs are expected to more than offset second-quarter tariff refunds, while higher raw-material and oil costs threaten margins in the second half. This leaves the earnings outlook exposed to costs that Colgate cannot fully control. (Reuters, Colgate-Palmolive)
Growth quality is still under pressure: Hill’s organic volume fell 1.8% in the second quarter, while Colgate’s exit from private-label pet food is expected to reduce 2026 organic sales growth by about 30 basis points. Reported growth therefore relies heavily on pricing and mix rather than stronger unit demand. (Colgate-Palmolive, Pet Food Processing)
Data summarised monthly by Lightyear AI. Last updated on 17 Sept 2026.
Colgate Financial Performance
Revenues and expenses
Colgate Earnings Performance
Company profitability
Upcoming events
Colgate News
AllArticlesVideos
Funds containing Colgate
AllEURGBPUSD
Fund name | Fund size | $CL weighting |
|---|---|---|
iShares S&P 500 Consumer Staples Sector€2B7D | €450M | 2.38% |
iShares S&P 500 Consumer Staples Sector£ICSU | £386M | 2.38% |
SPDR S&P US Dividend Aristocrats€SPYD | €3.3B | 0.98% |
SPDR S&P US Dividend Aristocrats£USDV | £2.8B | 0.98% |
Amundi S&P 500£500G | £6.6B | 0.82% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.